Related references
Note: Only part of the references are listed.First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study
Heinz-Josef Lenz et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
A systematic scoping review on natural killer cell function in colorectal cancer
Fiona S. W. Reid et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Multiregion single-cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancer
Wei Wang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study
John Kuruvilla et al.
LANCET ONCOLOGY (2021)
Cancer-Associated Fibroblast-Induced Resistance to Chemotherapy and Radiotherapy in Gastrointestinal Cancers
In-Hye Ham et al.
CANCERS (2021)
Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines
Yeong Hak Bang et al.
SCIENTIFIC REPORTS (2021)
Small RNAs in Seminal Plasma as Novel Biomarkers for Germ Cell Tumors
Nina Morup et al.
CANCERS (2021)
Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review
Tao Ouyang et al.
FRONTIERS IN ONCOLOGY (2021)
MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer
Xingchen Fan et al.
BIOSCIENCE REPORTS (2021)
Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II Trial
F. De Felice et al.
CLINICAL ONCOLOGY (2021)
Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer
Shukui Qin et al.
ONCOTARGETS AND THERAPY (2021)
Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis
Ute Jungwirth et al.
NATURE COMMUNICATIONS (2021)
Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities
Ali Hassanzadeh et al.
STEM CELL RESEARCH & THERAPY (2021)
Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models
Deepak Vangala et al.
GENOME MEDICINE (2021)
Exosome-Based Vaccines: History, Current State, and Clinical Trials
Patrick Santos et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Combination of Immune Checkpoint Blockade and Angiogenesis Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer
Sijia Ren et al.
FRONTIERS IN IMMUNOLOGY (2021)
Urinary Extracellular Vesicles for Renal Tubular Transporters Expression in Patients With Gitelman Syndrome
Chih-Chien Sung et al.
FRONTIERS IN MEDICINE (2021)
Perspectives of Microscopy Methods for Morphology Characterisation of Extracellular Vesicles from Human Biofluids
Mladenka Malenica et al.
BIOMEDICINES (2021)
Analysis of exosome-derived microRNAs reveals insights of intercellular communication during invasion of breast, prostate and glioblastoma cancer cells
Francesca Lessi et al.
CELL ADHESION & MIGRATION (2021)
Comparative analysis of dietary exosome-derived microRNAs from human, bovine and caprine colostrum and mature milk
Bohyun Yun et al.
JOURNAL OF ANIMAL SCIENCE AND TECHNOLOGY (2021)
The matrix in cancer
Thomas R. Cox
NATURE REVIEWS CANCER (2021)
STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis
Christina Heichler et al.
GUT (2020)
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164
Dung T. Le et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression
He Liu et al.
CLINICAL SCIENCE (2020)
Phenotype molding of T cells in colorectal cancer by single-cell analysis
Jiabo Di et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al.
NATURE (2020)
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial
Stefan Kasper et al.
CLINICAL COLORECTAL CANCER (2020)
Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27)
Emmanuelle Samalin et al.
CLINICAL COLORECTAL CANCER (2020)
Tumor-associated macrophages
Luca Cassetta et al.
CURRENT BIOLOGY (2020)
A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer
Mark Yarchoan et al.
CANCER MEDICINE (2020)
Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study
Faysal Dane et al.
BMJ OPEN (2020)
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial
Yelena Y. Janjigian et al.
LANCET ONCOLOGY (2020)
Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy
Liang Guo et al.
FRONTIERS IN IMMUNOLOGY (2020)
Regorafenib and Nivolumab or Pembrolizumab Combination and Circulating Tumor DNA Response Assessment in Refractory Microsatellite Stable Colorectal Cancer
Chongkai Wang et al.
ONCOLOGIST (2020)
Exosomal miR-200c-3p negatively regulates the migraion and invasion of lipopolysaccharide (LPS)-stimulated colorectal cancer (CRC)
Yimei Jiang et al.
BMC MOLECULAR AND CELL BIOLOGY (2020)
Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p-TGF-β1 axis
Anquan Shang et al.
MOLECULAR CANCER (2020)
Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer
Hannah Voss et al.
CLINICAL & EXPERIMENTAL METASTASIS (2020)
T Cell Receptor Is Required for Differentiation, but Not Maintenance, of Intestinal CD4+ Intraepithelial Lymphocytes
Angelina M. Bilate et al.
IMMUNITY (2020)
Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer
Chiara Cremolini et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer
Hamidreza Maminezhad et al.
LIFE SCIENCES (2020)
Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer
Ying Wang et al.
FRONTIERS IN IMMUNOLOGY (2020)
LAG-3: from molecular functions to clinical applications
Takumi Maruhashi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials
Nagendra S. Yarla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK- and NKT cells, and clinical outcome
Danielle Krijgsman et al.
MOLECULAR IMMUNOLOGY (2020)
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer
T. Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota
Marine Fidelle et al.
FRONTIERS IN IMMUNOLOGY (2020)
Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+effector memory T cell to Treg ratio
Erika J. Crosby et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Regulation of the intestinal barrier by nutrients: The role of tight junctions
Takuya Suzuki
ANIMAL SCIENCE JOURNAL (2020)
Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance)
Hao Xie et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
How the ageing microenvironment influences tumour progression
Mitchell Fane et al.
NATURE REVIEWS CANCER (2020)
Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy
Erik Henke et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma
Xinying Xue et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2020)
FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors
Leigh Marcus et al.
CLINICAL CANCER RESEARCH (2019)
Treatment sequencing in metastatic colorectal cancer
D. P. Modest et al.
EUROPEAN JOURNAL OF CANCER (2019)
The Role of Tumor-Associated Neutrophils in Colorectal Cancer
Rei Mizuno et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients
Lin Xiao et al.
MOLECULAR THERAPY (2019)
A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules
Margaret E. Gatti-Mays et al.
CLINICAL CANCER RESEARCH (2019)
Regulatory T cells and M2-polarized tumour-associated macrophages are associated with the oncogenesis and progression of oral squamous cell carcinoma
A. Kouketsu et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2019)
Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis
Chen Wei et al.
MOLECULAR CANCER (2019)
CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer
J. L. Hu et al.
MOLECULAR CANCER (2019)
Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer
Michael A. Morse et al.
ONCOLOGIST (2019)
Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients
Adam E. Snook et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Immune senescence and immune activation in elderly colorectal cancer patients
Silvia Giunco et al.
AGING-US (2019)
The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis
Lihu Gu et al.
BMC CANCER (2019)
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw et al.
CANCER RESEARCH (2019)
The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells
Evelyn Gerth et al.
FRONTIERS IN IMMUNOLOGY (2019)
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
NaNa Keum et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Intestinal Barrier Function in Gluten-Related Disorders
Danielle Cardoso-Silva et al.
NUTRIENTS (2019)
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy
S. J. Luen et al.
ANNALS OF ONCOLOGY (2019)
Foxp3 Post-translational Modifications and Treg Suppressive Activity
Guoping Deng et al.
FRONTIERS IN IMMUNOLOGY (2019)
Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancer
Tadamichi Denda et al.
CANCER SCIENCE (2019)
FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109)
Dominik P. Modest et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Role of diet and gut microbiota on colorectal cancer immunomodulation
Carolina Vieira De Almeida et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Elevated CD163+/CD68+ Ratio at Tumor Invasive Front is Closely Associated with Aggressive Phenotype and Poor Prognosis in Colorectal Cancer
Chaogang Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
PD-1 and cancer: molecular mechanisms and polymorphisms
Arash Salmaninejad et al.
IMMUNOGENETICS (2018)
A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma
Satoshi Murahashi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity
J. J. Worthington et al.
MUCOSAL IMMUNOLOGY (2018)
Regulatory T cells: a potential target in cancer immunotherapy
Kohei Shitara et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
TIM-3 Regulates CD103(+) Dendritic Cell Function and Response to Chemotherapy in Breast Cancer
Alvaro de Mingo Pulido et al.
CANCER CELL (2018)
The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations
Tomoyuki Sasano et al.
CLINICAL CANCER RESEARCH (2018)
Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis
Madelon Paauwe et al.
CLINICAL CANCER RESEARCH (2018)
PD-L1 expression in tumour-infiltrating lymphocytes is a poor prognostic factor for primary acral melanoma patients
Min Ren et al.
HISTOPATHOLOGY (2018)
Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer
Takeshi Ishikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer The FRESCO Randomized Clinical Trial
Jin Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer
Michael J. Overman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
Xiaolei Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Programmed cell death ligand-1 expression in tumor and immune cells is associated with better patient outcome and decreased tumor-infiltrating lymphocytes in uveal melanoma
Pablo Zoroquiain et al.
MODERN PATHOLOGY (2018)
Goblet cells: multifaceted players in immunity at mucosal surfaces
Kathryn A. Knoop et al.
MUCOSAL IMMUNOLOGY (2018)
Regulatory T cells in autoimmune disease
Margarita Dominguez-Villar et al.
NATURE IMMUNOLOGY (2018)
Myeloid-derived suppressor cells coming of age
Filippo Veglia et al.
NATURE IMMUNOLOGY (2018)
Extracellular vesicles in cancer - implications for future improvements in cancer care
Rong Xu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier
Danyvid Olivares-Villagomez et al.
TRENDS IN IMMUNOLOGY (2018)
Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial
Paul Ruff et al.
JOURNAL OF GERIATRIC ONCOLOGY (2018)
The dynamic change of neutrophil to lymphocyte ratio can predict clinical outcome in stage I-III colon cancer
Zhigui Li et al.
SCIENTIFIC REPORTS (2018)
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
Judith A. Seidel et al.
FRONTIERS IN ONCOLOGY (2018)
An Update of Efficacy and Safety of Cetuximab in Metastatic Colorectal Cancer: A Narrative Review
Giulia Fornasier et al.
ADVANCES IN THERAPY (2018)
Combinations of Bevacizumab With Cancer Immunotherapy
Daniel S. Chen et al.
CANCER JOURNAL (2018)
Surgical trauma contributes to progression of colon cancer by downregulating CXCL4 and recruiting MDSCs
Pingbo Xu et al.
EXPERIMENTAL CELL RESEARCH (2018)
Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study
Jin Li et al.
FUTURE ONCOLOGY (2018)
LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment
Changhao Chen et al.
NATURE COMMUNICATIONS (2018)
Not All Immune Checkpoints Are Created Equal
Annika De Sousa Linhares et al.
FRONTIERS IN IMMUNOLOGY (2018)
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis
Javier Rodriguez et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis
Arseniy E. Yuzhalin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
Seminal immunologic discoveries with direct clinical implications: The 2018 Nobel Prize in Physiology or Medicine honours discoveries in cancer immunotherapy
Hans-Gustaf Ljunggren et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2018)
Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis
Zhicheng Zeng et al.
NATURE COMMUNICATIONS (2018)
Colorectal cancer liver metastatic growth depends on PAD4-driven citrullination of the extracellular matrix
A. E. Yuzhalin et al.
NATURE COMMUNICATIONS (2018)
The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials
Giandomenico Roviello et al.
EUROPEAN JOURNAL OF CANCER (2017)
The colorectal cancer immune microenvironment and approach to immunotherapies
Minoru Koi et al.
FUTURE ONCOLOGY (2017)
Tim-3 and its role in regulating anti-tumor immunity
Madhumita Das et al.
IMMUNOLOGICAL REVIEWS (2017)
TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy
William C. Dougall et al.
IMMUNOLOGICAL REVIEWS (2017)
CCR6 promotes steady-state mononuclear phagocyte associationwith the intestinal epithelium, imprinting and immune surveillance
Keely G. McDonald et al.
IMMUNOLOGY (2017)
Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression
Huifang Shi et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms
Toshimitsu Yamaoka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer A Randomized Clinical Trial
Alan P. Venook et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
Joshua Bauml et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
Robert Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
Arjun V. Balar et al.
LANCET ONCOLOGY (2017)
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael J. Overman et al.
LANCET ONCOLOGY (2017)
Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers
Chengcheng Zhang et al.
MOLECULAR THERAPY (2017)
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
J. Bellmunt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Nasuh C. Buyukkaramikli et al.
PHARMACOECONOMICS (2017)
Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars
Lee S. Rosen et al.
TARGETED ONCOLOGY (2017)
Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo
Stephan Halle et al.
TRENDS IN IMMUNOLOGY (2017)
Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment
Yunqing Xie et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
Allograft inflammatory factor 1 is a regulator of transcytosis in M cells
Sari Kishikawa et al.
NATURE COMMUNICATIONS (2017)
Effect of Modified Vaccinia Ankara-5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer A Randomized Clinical Trial
Martin Scurr et al.
JAMA ONCOLOGY (2017)
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer
Kristen M. Hege et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
High levels of tumor-associated neutrophils are associated with improved overall survival in patients with stage II colorectal cancer
Ryan S. Berry et al.
PLOS ONE (2017)
Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer
David Lok Hang Chan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression
Rahul Bhome et al.
AGING-US (2017)
Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury
Christopher R. Heery et al.
CLINICAL CANCER RESEARCH (2017)
Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis
Tomohiro Murakami et al.
BRITISH JOURNAL OF CANCER (2017)
FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma
Amy Barone et al.
CLINICAL CANCER RESEARCH (2017)
Assessment of the relationship between neutrophil lymphocyte ratio and prognostic factors in non-metastatic colorectal cancer
Ersin Borazan et al.
TURKISH JOURNAL OF SURGERY (2017)
Microenvironmental regulation of tumour angiogenesis
Michele de Palma et al.
NATURE REVIEWS CANCER (2017)
B cell regulation in cancer and anti-Xtumor immunity
Anushruti Sarvaria et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome
Michael J. Cavnar et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
Rakesh R. Ramjiawan et al.
ANGIOGENESIS (2017)
Dendritic cells in cancer: the role revisited
Filippo Veglia et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies
Valentina Comunanza et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2017)
Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study
Tao Lin et al.
TUMOR BIOLOGY (2016)
Phenotyping of tumor-associated macrophages in colorectal cancer: Impact on single cell invasion (tumor budding) and clinicopathological outcome
Viktor H. Koelzer et al.
ONCOIMMUNOLOGY (2016)
Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis
Tobias Engel Ayer Botrel et al.
BMC CANCER (2016)
Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment Regimen
Emeric Limagne et al.
CANCER RESEARCH (2016)
PD-1/PD-L and autoimmunity: A growing relationship
Mohammad Reza Zamani et al.
CELLULAR IMMUNOLOGY (2016)
Autologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical Trial
Hua Zhao et al.
CLINICAL COLORECTAL CANCER (2016)
Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
Shao-Lai Zhou et al.
GASTROENTEROLOGY (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Roles of regulatory T cells in cancer immunity
Yoshiko Takeuchi et al.
INTERNATIONAL IMMUNOLOGY (2016)
Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer
Jonna Berntsson et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Occurrence and significance of tumor-associated neutrophils in patients with colorectal cancer
Maria Rosaria Galdiero et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Tumour-associated macrophages correlate with microvascular bed extension in colorectal cancer patients
Ilaria Marech et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Tumor macrophages are pivotal constructors of tumor collagenous matrix
Ran Afik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis
Erin A. Marshall et al.
MOLECULAR CANCER (2016)
The ever-expanding role of HIF in tumour and stromal biology
Edward L. LaGory et al.
NATURE CELL BIOLOGY (2016)
Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
Jeffrey J. Wallin et al.
NATURE COMMUNICATIONS (2016)
PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression
Xiao Xiao et al.
CANCER DISCOVERY (2016)
Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy
Helena Verdaguer et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2016)
Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer
John Pradeep Veluchamy et al.
PLOS ONE (2016)
The role of neutrophils in immune dysfunction during severe inflammation
Pieter H. C. Leliefeld et al.
CRITICAL CARE (2016)
Tumor Necrosis Factor α Decreases Glucagon-Like Peptide-2 Expression by Up-Regulating G-Protein-Coupled Receptor 120 in Crohn Disease
Takuya Tsukahara et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
Shannon L. Maude et al.
BLOOD (2015)
Phase I/II study of adjuvant immunotherapy with sentinel lymph node T lymphocytes in patients with colorectal cancer
Yun-Huan Zhen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer
Joseph P. Balint et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer
Li-Ying OuYang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
Chiara Cremolini et al.
LANCET ONCOLOGY (2015)
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S. Weber et al.
LANCET ONCOLOGY (2015)
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
Jin Li et al.
LANCET ONCOLOGY (2015)
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix et al.
LANCET ONCOLOGY (2015)
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
Josep Tabernero et al.
LANCET ONCOLOGY (2015)
New developments in goblet cell mucus secretion and function
G. M. H. Birchenough et al.
MUCOSAL IMMUNOLOGY (2015)
Matrix stiffness drives epithelial mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway
Spencer C. Wei et al.
NATURE CELL BIOLOGY (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay et al.
SEMINARS IN CANCER BIOLOGY (2015)
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study
Lorenzo Antonuzzo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Tenascin C in metastasis: A view from the invasive front
Camille M. Lowy et al.
CELL ADHESION & MIGRATION (2015)
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
Bin Shang et al.
SCIENTIFIC REPORTS (2015)
CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function
Eunyoung Chun et al.
CELL REPORTS (2015)
Neutrophils in Cancer: Two Sides of the Same Coin
Eileen Uribe-Querol et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge
Amani Makkouk et al.
CANCER RESEARCH (2015)
Macrophage-secreted IL-8 induces-epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway
Xiu-Tao Fu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Microbial sensing by goblet cells controls immune surveillance of luminal antigens in the colon
K. A. Knoop et al.
MUCOSAL IMMUNOLOGY (2015)
Effects of cytokine-induced killer cell treatment in colorectal cancer patients: A retrospective study
Jinying Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
From Truly Naive to Exhausted Senescent T Cells: When Markers Predict Functionality
Anis Larbi et al.
CYTOMETRY PART A (2014)
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial
Josep Tabernero et al.
EUROPEAN JOURNAL OF CANCER (2014)
Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis
Malin E. V. Johansson et al.
GUT (2014)
Different subsets of natural killer T cells may vary in their roles in health and disease
Vipin Kumar et al.
IMMUNOLOGY (2014)
Allograft inflammatory factor-1 augments macrophage phagocytotic activity and accelerates the progression of atherosclerosis in ApoE−/− mice
Tetsuya Mishima et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
Edward B. Garon et al.
LANCET (2014)
Comparative transcriptional and functional profiling defines conserved programs of intestinal DC differentiation in humans and mice
Payal B. Watchmaker et al.
NATURE IMMUNOLOGY (2014)
Characterization of tumor-associated B-cell subsets in patients with colorectal cancer
Alexander Shimabukuro-Vornhagen et al.
ONCOTARGET (2014)
Desmoplasia and Chemoresistance in Pancreatic Cancer
Marvin Schober et al.
CANCERS (2014)
A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer
Michael A. Morse et al.
ANNALS OF SURGERY (2013)
Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer
M. Ishizuka et al.
BRITISH JOURNAL OF CANCER (2013)
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
Michael A. Morse et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial
Josep Tabernero et al.
CLINICAL CANCER RESEARCH (2013)
Antiangiogehic Drugs for Colorectal Cancer: Exploring New Possibilities
Renata Ferrarotto et al.
CLINICAL COLORECTAL CANCER (2013)
Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients
Yamila S. Rocca et al.
INNATE IMMUNITY (2013)
Hepatic stellate cells in liver development, regeneration, and cancer
Chunyue Yin et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial
Alfredo Carrato et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Multiplex B Cell Characterization in Blood, Lymph Nodes, and Tumors from Patients with Malignancies
A. Ali Zirakzadeh et al.
JOURNAL OF IMMUNOLOGY (2013)
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Axel Grothey et al.
LANCET (2013)
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial
David Cunningham et al.
LANCET ONCOLOGY (2013)
Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma
Risheng Que et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions
Patrick J. Brennan et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature
Alexander Stein et al.
BMC CANCER (2012)
First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: A phase II study
Yasushi Tsuji et al.
CANCER SCIENCE (2012)
Analysis of exosome release and its prognostic value in human colorectal cancer
J. Silva et al.
GENES CHROMOSOMES & CANCER (2012)
The extracellular matrix: A dynamic niche in cancer progression
Pengfei Lu et al.
JOURNAL OF CELL BIOLOGY (2012)
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans
Emily Corse et al.
JOURNAL OF IMMUNOLOGY (2012)
Identification and proteomic profiling of exosomes in human cerebrospinal fluid
Jonathan M. Street et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
Aimery de Gramont et al.
LANCET ONCOLOGY (2012)
Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine
Jeremiah R. McDole et al.
NATURE (2012)
A Randomized, Phase II Trial of Standard Triweekly Compared with Dose-Dense Biweekly Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer: XELOX-A-DVS (Dense Versus Standard)
Herbert Hurwitz et al.
ONCOLOGIST (2012)
Increased Intratumoral Neutrophil in Colorectal Carcinomas Correlates Closely with Malignant Phenotype and Predicts Patients' Adverse Prognosis
Hui-Lan Rao et al.
PLOS ONE (2012)
Origins of the Tumor Microenvironment: Quantitative Assessment of Adipose-Derived and Bone Marrow-Derived Stroma
Shannon Kidd et al.
PLOS ONE (2012)
Plasma-Derived Exosomal Survivin, a Plausible Biomarker for Early Detection of Prostate Cancer
Salma Khan et al.
PLOS ONE (2012)
B Cells Contribute to the Antitumor Activity of CpG-Oligodeoxynucleotide in a Mouse Model of Metastatic Lung Carcinoma
Rosalinda Sorrentino et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer
Marcia S. Brose et al.
BMC CANCER (2011)
The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model
Tamar Tadmor et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines
Niels Halama et al.
CLINICAL CANCER RESEARCH (2011)
Functional Specializations of Intestinal Dendritic Cell and Macrophage Subsets That Control Th17 and Regulatory T Cell Responses Are Dependent on the T Cell/APC Ratio, Source of Mouse Strain, and Regional Localization
Timothy L. Denning et al.
JOURNAL OF IMMUNOLOGY (2011)
Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages
Cecilia Lasser et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Macrophage regulation of tumor angiogenesis: Implications for cancer therapy
Mario Leonardo Squadrito et al.
MOLECULAR ASPECTS OF MEDICINE (2011)
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
Maria R. Parkhurst et al.
MOLECULAR THERAPY (2011)
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria
Yuki Kinjo et al.
NATURE IMMUNOLOGY (2011)
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
Helga Ellingsgaard et al.
NATURE MEDICINE (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer
Mona Karlsson et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients
Raphael Marechal et al.
BMC CANCER (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
A Randomized Trial of Ex vivo CD40L Activation of a Dendritic Cell Vaccine in Colorectal Cancer Patients: Tumor-Specific Immune Responses Are Associated with Improved Survival
Richard J. Barth et al.
CLINICAL CANCER RESEARCH (2010)
Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells
I. Hadjiyanni et al.
DIABETOLOGIA (2010)
High frequency of tumor-infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients
Daniel M. Frey et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Higher intratumoral infiltrated Foxp3+Treg numbers and Foxp3+/CD8+ratio are associated with adverse prognosis in resectable gastric cancer
Zhengbin Shen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
Jean-Yves Douillard et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice
David J. DiLillo et al.
JOURNAL OF IMMUNOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Development of Monocytes, Macrophages, and Dendritic Cells
Frederic Geissmann et al.
SCIENCE (2010)
Adaptive-Control Model for Neutrophil Orientation in the Direction of Chemical Gradients
Daniel Irimia et al.
BIOPHYSICAL JOURNAL (2009)
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
Mojgan Ahmadzadeh et al.
BLOOD (2009)
Phase III Trial of FOLFOX plus Bevacizumab or Cediranib (AZD2171) as First-Line Treatment of Patients with Metastatic Colorectal Cancer: HORIZON III
Jane D. Robertson et al.
CLINICAL COLORECTAL CANCER (2009)
Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
Bernard Escudier et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Large-Scale Proteomics and Phosphoproteomics of Urinary Exosomes
Patricia A. Gonzales et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
Jolien Tol et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
Takuya Osada et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
The Desmoplastic Reaction Surrounding Hepatic Colorectal Adenocarcinoma Metastases Aids Tumor Growth and Survival via αv Integrin Ligation
John A. Conti et al.
CLINICAL CANCER RESEARCH (2008)
Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer
Shengming Dai et al.
MOLECULAR THERAPY (2008)
Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis
Christian Stockmann et al.
NATURE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts
Elisabeth M. Zeisberg et al.
CANCER RESEARCH (2007)
Exosomes with immune modulatory features are present in human breast milk
Charlotte Admyre et al.
JOURNAL OF IMMUNOLOGY (2007)
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The terminology issue for myeloid-derived suppressor cells
Dmitry I. Gabrilovich et al.
CANCER RESEARCH (2007)
NKT cells: T lymphocytes with innate effector functions
Luc Van Kaer
CURRENT OPINION IN IMMUNOLOGY (2007)
Tumour-associated angiogenesis in human colorectal cancer
K. A. Rmali et al.
COLORECTAL DISEASE (2007)
K-ras activation generates an inflammatory response in lung tumors
H Ji et al.
ONCOGENE (2006)
Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer
N Personeni et al.
SEMINARS IN ONCOLOGY (2005)
Increased intratumor Vα24-positive natural killer T cells:: A prognostic factor for primary colorectal carcinomas
T Tachibana et al.
CLINICAL CANCER RESEARCH (2005)
Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer
GS Frick et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2005)
Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor
LB Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Identification and proteomic profiling of exosomes in human urine
T Pisitkun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis
A Gardini et al.
JOURNAL OF SURGICAL ONCOLOGY (2004)
PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease
ER Vossenaar et al.
BIOESSAYS (2003)
IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer
RS Herbst et al.
SEMINARS IN ONCOLOGY (2002)
NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells
MC Coles et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
